News Wire ~ 3rd Party Press Release
Why Immunotherapy for Peanut Allergy Works for Some, Not Everyone
Researchers make progress in peanut allergy immunotherapy using a new approach.
Company Completes Enrollment for Phase 2 Trial of “Immune Resetting” Peptide for Allergic Diseases
Topline data anticipated in Q2 2023.
Positive Results from Phase 3 Study of PALFORZIA® in Peanut-Allergic Children Aged 1 to...
73.5% of patients treated met the primary outcome at 12 months compared with 6.3% of patients in the placebo arm.
Only 52% of Adults with Severe Food Allergy Have Been Prescribed an Epinephrine Auto-Injector
36% of adults believe epinephrine auto-injectors cause life-threatening effects.
Experimental Cat Allergy Shots Provide Longer-Lasting Relief
This approach might also be effective for other types of allergies, including food allergies.
Study Shows Care from an Allergist Results in Lower Health Care Costs for Children...
Researcher used big datasets to show allergist care correlates with a decrease in total health care costs for those with peanut allergy.
Esophageal String Test®, a Less Invasive Way to Monitor Adults and Children EoE, Launches...
Test offers EoE patients a simple, clinically proven method to control their disease.
Aquestive Receives Positive FDA Response to Epinephrine Sublingual Film Phase 2 Trial
Response confirms approach and supports the characterization of their novel drug platform.
Children with Food Allergy-Related Anxiety Benefit from Cognitive Behavioral Therapy
Study shows exposure-based interventions helps both food allergic children and their parents.
CHOP’s Food Allergy Bravery Clinic Helps Kids with Food Allergies Overcome Anxiety
First-of-its-kind program led to significant declines in anxiety for those with food allergies and improvements in quality of life.
